Mizuho reiterates Outperform on Strategy stock, $320 target

Strategy (MSTR) received a reaffirmed Outperform from Mizuho with a $320 price target, as the firm said Bitcoin accumulation remains the company’s core strategy and its financing model benefits from institutional adoption. However, first-quarter fiscal 2026 results were weak, with EPS of -$38.25 versus -$18.98 expected and revenue of $124.3 million versus $125.07 million expected, driven by a $14.5 billion mark-to-market Bitcoin loss. The company also signaled it may sell some Bitcoin to meet preferred dividend and convertible debt obligations, underscoring a more mixed capital strategy.

Analysis

The key market implication is not the accounting loss; it is that MSTR is increasingly behaving like a leveraged, path-dependent funding vehicle for Bitcoin rather than a conventional operating equity. As long as BTC stays range-bound or trends higher, the company can keep refinancing volatility into accretive capital raises; if BTC draws down sharply, that same reflexivity turns negative fast because preferreds, converts, and equity issuance all become more expensive at the same time. That makes the stock less about steady fundamentals and more about regime stability in crypto liquidity.

The second-order winner is the broader BTC treasury complex and capital-markets intermediaries that benefit from tighter spreads and repeated issuance windows. If institutions continue treating BTC as a balance-sheet asset, MSTR’s “proxy premium” can persist longer than fundamentals would suggest, but the premium is fragile because it depends on investors accepting dilution as a feature rather than a bug. The main loser is any investor underwriting MSTR as a pure operating turnaround: upside is capped by BTC beta, while downside can widen quickly if financing markets demand a higher risk premium.

Catalyst timing matters: over the next 1-4 weeks, the stock likely trades off BTC spot, implied crypto vol, and headlines around whether management leans further into liability management or signals any forced monetization. Over 3-6 months, the real test is whether institutional BTC adoption keeps compressing funding spreads enough to offset mark-to-market volatility; if not, MSTR’s cost of capital can reprice abruptly. The contrarian point: consensus is still anchored to BTC upside, but the more important asymmetric risk is a volatility crush that removes the financing advantage even if BTC does not fall much.

Key Decisions for Investors

• Short MSTR vs long BTC spot or BTC ETF (IBIT/FBTC) for 1-3 months: expresses the view that the equity premium is overstated and should compress if financing flexibility becomes less special; target a 15-25% relative move, stop if MSTR premium expands on fresh issuance.
• Buy MSTR downside via put spreads 2-4 months out: favor 10-15% OTM spreads to capture a repricing if BTC slips or capital-markets sentiment turns; risk is limited premium, payoff improves sharply on a volatility spike.
• For directional BTC bulls, prefer IBIT over MSTR for 3-6 months: lower governance and dilution risk, less sensitivity to balance-sheet leverage, better risk-adjusted exposure if the thesis is simply BTC appreciation.
• If staying long MSTR, pair with a BTC hedge on a 30-60 day horizon: reduce gap risk from dilution/financing headlines while preserving some upside to renewed treasury accumulation.
• Avoid chasing MSTR strength after large BTC up days: the stock’s reflexive upside is highest when issuance is cheap, but entry after momentum spikes typically compresses forward returns once the market re-prices dilution.